Coda Therapeutics, Inc.

Coda Technologies, Inc.

Grove Matsuoka

Bradford James Duft

Anthony Phillips

David Pool

Tracey Sunderland

Scott Bannan

David Eisenbud

This invention concerns improved methods, uses, and kits for treating chronic wounds through the administration of anti-connexin agents, particularly anti-connexin 43 antisense polynucleotides. The methods, uses, and kits of the invention are based on the surprising and unexpected discovery that chronic wounds that do not increase or decrease in size by more than a pre-determined amount during a pre-treatment phase are more amenable to successful treatment than wounds whose size varies outside the target range during the pre-treatment phase.

Wound healing compositions and treatments

Growing community of inventors

San Diego, CA, United States of America

Grove Matsuoka